These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7388548)
41. Trials of antiplatelet drugs: some methodological considerations. Armitage P Rev Epidemiol Sante Publique; 1979 Sep; 27(2):87-90. PubMed ID: 538303 [No Abstract] [Full Text] [Related]
42. [Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?]. Mannucci PM G Ital Cardiol; 1983 Nov; 13(11):335-9. PubMed ID: 6667821 [No Abstract] [Full Text] [Related]
50. [Infarction prophylaxis--prevention of the sudden heart death? An alternative]. Gross F MMW Munch Med Wochenschr; 1982 May; 124(18):435-6. PubMed ID: 6124885 [No Abstract] [Full Text] [Related]
51. Role of platelet-active drugs in coronary artery disease. Sherry S Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025 [No Abstract] [Full Text] [Related]
52. [Role of platelet anti-aggregants in cardiovascular surgery]. Limet R Rev Med Liege; 1987 May; 42(10):493-5. PubMed ID: 3497419 [No Abstract] [Full Text] [Related]
53. Antithrombotic treatment. Buckler P; Douglas AS Br Med J (Clin Res Ed); 1983 Jul; 287(6386):196-8. PubMed ID: 6191822 [No Abstract] [Full Text] [Related]
54. [Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy]. Loo J Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):172-94. PubMed ID: 50982 [No Abstract] [Full Text] [Related]
55. [Hypercoagulability and cerebral infarction]. Matsuda T No To Shinkei; 1986 Apr; 38(4):317-27. PubMed ID: 3013261 [No Abstract] [Full Text] [Related]
56. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes. Sherry S Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782 [No Abstract] [Full Text] [Related]
57. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures. Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857 [No Abstract] [Full Text] [Related]
58. Status of antiplatelet drugs in coronary heart disease. Mehta J; Mehta P JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365 [No Abstract] [Full Text] [Related]